These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
197 related articles for article (PubMed ID: 34667106)
21. Determining the optimal dose of tenecteplase before endovascular therapy for ischemic stroke (EXTEND-IA TNK Part 2): A multicenter, randomized, controlled study. Campbell BC; Mitchell PJ; Churilov L; Yassi N; Kleinig TJ; Yan B; Thijs V; Desmond PM; Parsons MW; Donnan GA; Davis SM Int J Stroke; 2020 Jul; 15(5):567-572. PubMed ID: 31564231 [TBL] [Abstract][Full Text] [Related]
22. Tenecteplase versus alteplase for early treatment of ischaemic stroke. Hudaib AR Lancet Neurol; 2022 Nov; 21(11):959. PubMed ID: 36270301 [No Abstract] [Full Text] [Related]
23. Tenecteplase for the treatment of acute ischemic stroke: A review of completed and ongoing randomized controlled trials. Coutts SB; Berge E; Campbell BC; Muir KW; Parsons MW Int J Stroke; 2018 Dec; 13(9):885-892. PubMed ID: 30035698 [TBL] [Abstract][Full Text] [Related]
25. Freezing Tenecteplase Into Aliquots to Reduce Waste in Acute Ischemic Stroke. Kaur H; Merkel A; Hackett CT; Finoli L; Seidl E; Reardon C; Cerejo R Stroke; 2024 Jan; 55(1):e1-e2. PubMed ID: 38063015 [No Abstract] [Full Text] [Related]
26. Tenecteplase: More Evidence It Should Replace Alteplase for Ischemic Stroke Treatment. Kreitzer N Ann Emerg Med; 2023 Dec; 82(6):729-731. PubMed ID: 37598332 [No Abstract] [Full Text] [Related]
27. Tenecteplase versus alteplase for early treatment of ischaemic stroke - Authors' reply. Churilov L; Bivard A; Parsons MW Lancet Neurol; 2022 Nov; 21(11):959. PubMed ID: 36270302 [No Abstract] [Full Text] [Related]
28. Tenecteplase versus alteplase in acute ischemic stroke: systematic review and meta-analysis. Thelengana A; Radhakrishnan DM; Prasad M; Kumar A; Prasad K Acta Neurol Belg; 2019 Sep; 119(3):359-367. PubMed ID: 29728903 [TBL] [Abstract][Full Text] [Related]
29. Different doses of tenecteplase vs alteplase in thrombolysis therapy of acute ischemic stroke: evidence from randomized controlled trials. Xu N; Chen Z; Zhao C; Xue T; Wu X; Sun X; Wang Z Drug Des Devel Ther; 2018; 12():2071-2084. PubMed ID: 30013325 [TBL] [Abstract][Full Text] [Related]
30. A randomized trial of tenecteplase versus alteplase for acute ischemic stroke. Parsons M; Spratt N; Bivard A; Campbell B; Chung K; Miteff F; O'Brien B; Bladin C; McElduff P; Allen C; Bateman G; Donnan G; Davis S; Levi C N Engl J Med; 2012 Mar; 366(12):1099-107. PubMed ID: 22435369 [TBL] [Abstract][Full Text] [Related]
31. Effect of Intravenous Tenecteplase Dose on Cerebral Reperfusion Before Thrombectomy in Patients With Large Vessel Occlusion Ischemic Stroke: The EXTEND-IA TNK Part 2 Randomized Clinical Trial. Campbell BCV; Mitchell PJ; Churilov L; Yassi N; Kleinig TJ; Dowling RJ; Yan B; Bush SJ; Thijs V; Scroop R; Simpson M; Brooks M; Asadi H; Wu TY; Shah DG; Wijeratne T; Zhao H; Alemseged F; Ng F; Bailey P; Rice H; de Villiers L; Dewey HM; Choi PMC; Brown H; Redmond K; Leggett D; Fink JN; Collecutt W; Kraemer T; Krause M; Cordato D; Field D; Ma H; O'Brien B; Clissold B; Miteff F; Clissold A; Cloud GC; Bolitho LE; Bonavia L; Bhattacharya A; Wright A; Mamun A; O'Rourke F; Worthington J; Wong AA; Levi CR; Bladin CF; Sharma G; Desmond PM; Parsons MW; Donnan GA; Davis SM; JAMA; 2020 Apr; 323(13):1257-1265. PubMed ID: 32078683 [TBL] [Abstract][Full Text] [Related]
32. Comparison of dosing errors between tenecteplase and alteplase for management of acute ischemic stroke. Ray B; Janzen KM; Curran M; Adamson R; Allen L; Warach S; Daley M J Am Pharm Assoc (2003); 2023; 63(2):643-647. PubMed ID: 36623954 [TBL] [Abstract][Full Text] [Related]
33. Tenecteplase for Acute Ischemic Stroke: Current Evidence and Practical Considerations. Rabinstein AA; Golombievski E; Biller J CNS Drugs; 2020 Oct; 34(10):1009-1014. PubMed ID: 32785891 [TBL] [Abstract][Full Text] [Related]
34. IV tenecteplase: A non-inferior alternative to alteplase? Zubair AS; Sheth KN Med; 2022 Aug; 3(8):519-520. PubMed ID: 35963230 [TBL] [Abstract][Full Text] [Related]
35. A qualitative study of barriers and facilitators to using tenecteplase to treat acute ischemic stroke. Prasad S; Jones EM; Gebreyohanns M; Aguilera V; Olson DM; Anderson JA; Savitz SI; Flores SC; Warach SJ; Rhodes CE; Goldberg MP; Ifejika NL J Stroke Cerebrovasc Dis; 2024 Jan; 33(1):107458. PubMed ID: 37956644 [TBL] [Abstract][Full Text] [Related]
36. Ethical Justification for Deferral of Consent in the AcT Trial for Acute Ischemic Stroke. Faris H; Dewar B; Dowlatshahi D; Ramji A; Kenney C; Page S; Buck B; Hill MD; Coutts SB; Almekhlafi M; Sajobi T; Singh N; Sehgal A; Swartz RH; Menon BK; Shamy M Stroke; 2022 Jul; 53(7):2420-2423. PubMed ID: 35603597 [TBL] [Abstract][Full Text] [Related]